< Timeline >
April 2, 2021
Lazarex Cancer Foundation’s new Cancer Wellness Hub is a safe space for community members to talk about their questions in relation to the entire continuum of cancer care. Founder and CEO DanaDornsife joins Michael Toscano on First Light to explain (starts @ 18:00) #MinorityHealthMonth
< Timeline >
December 30, 2020
December Newsletter: Video message from Lazarex COO Vera Packard, What I Am Grateful For In 2020 by Lazarex founder and CEO Dana Dornsife, LCF Patient Gail’s update, Meet Marya L. Shegog, PhD, MPH, CHES: Lazarex Health Equity and Diversity Coordinator, 2020 Year End Appeal, Major Victory for Thousands of Massachusetts Cancer Patients.
October 30, 2020
Barriers to Clinical Trial Participation: Patient Empowerment Network series of interviews with Dana Dornsife, founder of Lazarex Cancer Foundation, about the key barriers to clinical trial participation, what are virtual trials, and how COVID-19 has really opened the door for a lot of opportunity to engage with patients around clinical trials.
October Newsletter: Lazarex Gala recap, In Memory of Chip Hollister, Introducing Lazarex PATH – a new Lazarex Program, Lazarex in the News – How Dana Dornsife of Lazarex Cancer Foundation Is Helping To Improve The Outcome of Cancer Care, Lazarex in the News – WBALTV 11: Coronavirus pandemic exposes hard truths about racial disparities in the healthcare industry, Write a Review to Help Lazarex be a Top Rated Nonprofit in 2020.
October 23, 2020
CISCRP Honors “Medical Heroes,” Participants in Clinical Trials: The AWARE for All online event featured a keynote and overview presentation followed by a panel discussion; virtual health exercises. Panel discussions included LCF Board Member Jonathan Jackson and LCF client Ashely Kulp.
September 24, 2020
Press Release: New Study Puts Spotlight on Major Health Disparities – A new report sponsored by Lazarex Cancer Foundation calls attention to the serious disparities in cancer rates and outcomes. The “State of Cancer in Philadelphia” was issued this week as a collaboration between Drexel University’s Urban Health Collaborative, the Philadelphia Department of Public Health, and the Fox Chase Cancer Center.
September 11, 2020
BioTech IQ Podcast: When Dana’s brother-in-law was diagnosed with pancreatic cancer she helped her family discover the power of access to clinical trials. That led her founding Lazarex Cancer Foundation, a non-profit organization that helps people find clinical trials and deal with the costs associated. Dana has literally worked to induce change on how the FDA views reimbursements to patients from pharma companies and her foundation is doing some amazing things to further diversity. Listen for the whole story!
April 21, 2020
Virtual Clinical Trials for COVID-19 Could Change Study of Other Diseases: Doreen Gentzler of NBC4 Washington interviews Lazarex patient Mike Snyder, Lazarex Cancer Foundation CEO Dana Dornsife, and Dr. Louis Weiner, Director of the Georgetown Lombardi Comprehensive Cancer Center.
April 17, 2020
Novel coronavirus opens the door for remote clinical trial participation: Micah Smith of ABC Denver7 interviews Lazarex founder & CEO Dana Dornsife, UCSF oncologist Dr. Hala Borno and Lazarex patient Mike Snyder about the changing landscape for clinical trial participation due to the coronavirus.
April 16, 2020
Helping Cancer Patients Access Clinical Trials During National Minority Cancer Awareness Week: As our nation addresses the COVID-19 pandemic and seeks to develop a vaccine, it has become abundantly clear how important clinical trials are. Radio interview and article with Dana Dornsife, Founder and CEO of Lazarex Cancer Foundation.
April 15, 2020
Clinical Trial Participation Act Aims To Ease Patient Reimbursement For Trials: A non-profit foundation is spearheading legislation that give thousands of underserved and hopeful cancer patients access to clinical trials and potential life-saving drugs. The Clinical Trial Participation Act reiterates FDA guidance that reimbursing patients for out-of-pocket travel expenses associated with cancer clinical trials is not considered coercion or inducement.
April 9, 2020
KTVU’s Claudine Wong in conversation with UCSF’s Dr. Hala Borno, Dana Dornsife and Lazarex Cancer Foundation VIP (Very Important Patient) Becky Stephens on the new rules of engagement regarding how we conduct cancer clinical trials in the face of COVID-19 and what it could mean for patients moving forward.
March 11, 2020
Among the flurry of bills signed into law by Gov. Tony Evers last week, one that didn’t get much attention stands to help cancer patients and their families throughout Wisconsin. The bill, SB 489, passed on voice votes in both the Assembly and Senate with full bipartisan support, addresses economic barriers faced by cancer patients to participate in life-sustaining clinical trials.
February 26, 2020
Lazarex Cancer Foundation and Perthera unite to advance Clinical Trial Access and Enrollment for Cancer Patients. They will be focused on matching and enrolling patients in clinical trials through Lazarex IMPACT and CARE programs, by utilizing Perthera’s treatment-matching Artificial Intelligence (AI) technology and other elements of the Perthera Platform to advance precision medicine for cancer patients.
February 26, 2020
The Ritz Herald: llinois Lawmakers announce a new law that will help thousands of cancer patients in the state. SB1711, the Clinical Trial Participation Act gives all Illinois cancer patients new hope by providing access to potentially life-saving breakthrough medical advancements in clinical trials.
February 24, 2020
Major Victory For Cancer Patients In Illinois: Illinois Lawmakers announce a new law that will help thousands of cancer patients in the state. SB1711, the Clinical Trial Participation Act gives all Illinois cancer patients new hope by providing access to potentially life-saving breakthrough medical advancements in clinical trials.
February 24, 2020
NBC 5 Chicago: Clinical trials can save the lives of cancer patients, but studies show minorities and the poor often don’t participate, because they simply can’t afford to. Parking costs and travel expenses add up, but a new law in Illinois allows patients to get reimbursed for those expenses. Includes interview with Lazarex Cancer Foundation’s Dana Dornsife.
February 24, 2020
WTTW PBS Chicago Tonight interview with Dana Dornsife, Founder of Lazarex Cancer Foundation; Dr. Leon Platanias, Director of the Northwestern University Robert H. Lurie Comprehensive Cancer Center; and Theresa Staten, who has been participating in a clinical drug trial with assistance from Lazarex Cancer Foundation, about The Cancer Clinical Trial Participation Act, Senate Bill 1711, recently signed into law.
February 24, 2020
Chicago Tribune: New law will provide Illinois cancer patients funds to attend clinical trials: The Clinical Trial Participation Act was formally announced Wednesday. The legislation, which was signed Dec. 20, aims to increase participation in clinical trials by removing primary barriers for patients, a big one being finances.
February 5, 2020
All men are not created equal in the world of cancer. That is one message from Hala Borno, MD, PhD, a medical oncologist focusing on genitourinary malignancies at the UCSF Helen Diller Family Comprehensive Cancer Center. “I have a research interest in addressing disparities, the reflection of differences that lead to inequity,” she told Oncology Times.
January 30, 2020
Greenphire, the global leader in financial software for clinical trials, today announced that its CEO, Jim Murphy, will co-present alongside Lazarex Cancer Foundation Founder, Dana Dornsife, at the Society for Clinical Research Sites (SCRS)’s annual Global Oncology Site Solutions Summit.
< Timeline >
December 19, 2019
Ed Miesta, Chief Editor of Clinical Leader, discusses Patient Diversity in Clinical Trials – the barriers for minority populations and initiatives to address the problem with Dana Dornsife (Lazarex Cancer Foundation), Stephanie Monroe (African Americans against Alzheimer’s) and Dr. Fabian Sandoval (Emerson Clinical Research Institute).
November 13, 2019
NCCS Presents 4th Annual Ellen L. Stovall Award to Dr. Harmar Brereton and Dana Dornsife for Their Innovation and Dedication to Cancer Survivors Congressman Mark DeSaulnier (CA-11), a cancer survivor, presented the award to his constituent, Mrs. Dornsife. View the video honoring Dana Dornsife, Cancer Advocacy Innovator, at the award ceremony.
October 30, 2019
Lazarex Cancer Foundation is featured on PBS Newshour: Why minority representation in medical research is a matter of life and death. The country’s diversity is becoming ever greater, but medical research that could benefit the populace is not keeping pace. Special correspondent Cat Wise has the story.
September 30, 2019
Wrapping Up the Lazarex Gala – Lazarex Cancer Foundation’s “Treasure the Moments” gala was a memorable evening for everyone who attended. With a full house of more than 200 guests, the event raised $291,980 (net) due to very generous and spirited giving! Read the RECAP here. Check out gala photos here.
August 27, 2019
New Texas law will help cover some costs for cancer treatment patients Lazarex VIP (Very Important Patient) Charmaine Sarpong and Founder Dana Dornsife speak with Fox 4 Dallas reporter Dionne Anglin about the legislation in Texas that is effective 9/1 and will help 10’s of thousands of the state’s cancer patients gain access to clinical trials.
June 4, 2019
How Cultural Competence Could Help Boost Diversity in Clinical Research – If studies lack diversity, we’ll lack a clear picture of whether a treatment will work in all populations… Dana Dornsife, founder of Lazarex Cancer Foundation, acknowledged that there is no one-size-fits-all solution…
May 30, 2019
USC researchers offer financial aid to increase participation in clinical trials. Researchers depend on a wide variety of people signing up for clinical trials, so they can get the most diverse results. But participating in research can be time-consuming and costly… Lazarex Foundation provides the funding…
January 9, 2019
ASCO policy statement targets financial barriers to clinical trial participation – A policy statement issued by ASCO emphasizes the importance of increasing participation in cancer clinical research trials and outlines recommendations to improve access for underserved populations.